Evaluation of Short and Tall Stature in Children.

Short stature is defined as a height more than two standard deviations below the mean for age (less than the 3rd percentile). Tall stature is defined as a height more than two standard deviations above the mean for age (greater than the 97th percentile). The initial evaluation of short and tall stature should include a history and physical examination, accurate serial measurements, and determination of growth velocity, midparental height, and bone age. Common normal variants of short stature are familial short stature, constitutional delay of growth and puberty, and idiopathic short stature. Pathologic causes of short stature include chronic diseases; growth hormone deficiency; and genetic disorders, such as Turner syndrome. Tall stature has the same prevalence as short stature, but it is a much less common reason for referral to subspecialty care. Common causes of tall stature include familial tall stature, obesity, Klinefelter syndrome, Marfan syndrome, and precocious puberty. Although most children with short or tall stature have variants of normal growth, children who are more than three standard deviations from the mean for age are more likely to have underlying pathology. Evaluation for pathologic etiologies is guided by history and physical examination findings.

[1]  Y. Memon,et al.  To determine frequency of etiological factors in short statured patients presenting at an endocrine clinic of a tertiary care hospital , 2014, Pakistan journal of medical sciences.

[2]  T. Cheetham,et al.  Investigation and management of tall stature , 2014, Archives of Disease in Childhood.

[3]  L. Cohen Idiopathic short stature: a clinical review. , 2014, JAMA.

[4]  A. Rogol,et al.  Etiologies and early diagnosis of short stature and growth failure in children and adolescents. , 2014, The Journal of pediatrics.

[5]  T. Cheetham,et al.  Investigation and management of short stature , 2014, Archives of Disease in Childhood.

[6]  Sanjay Kumar Tall stature in children: differential diagnosis and management , 2013, International Journal of Pediatric Endocrinology.

[7]  P. Backeljauw,et al.  Low incidence of pathology detection and high cost of screening in the evaluation of asymptomatic short children. , 2013, The Journal of pediatrics.

[8]  L. Grummer-Strawn,et al.  Use of World Health Organization and CDC Growth Charts for Children Aged 0–59 Months in the United States (Excerpt) , 2010, Clinical Lactation.

[9]  P. Cohen,et al.  Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop. , 2008, The Journal of clinical endocrinology and metabolism.

[10]  B. U. Nwosu,et al.  Evaluation of short and tall stature in children. , 2008, American family physician.

[11]  S. van Buuren,et al.  The diagnostic work up of growth failure in secondary health care; An evaluation of consensus guidelines , 2008, BMC pediatrics.

[12]  T. Morgan Turner syndrome: diagnosis and management. , 2007, American family physician.

[13]  H. Storr,et al.  Paediatric Cushing's syndrome: epidemiology, investigation and therapeutic advances , 2007, Trends in Endocrinology & Metabolism.

[14]  P. Czernichow,et al.  CONSENSUS STATEMENT: Management of the Child Born Small for Gestational Age through to Adulthood: A Consensus Statement of the International Societies of Pediatric Endocrinology and the Growth Hormone Research Society , 2007 .

[15]  K. Copeland,et al.  A general pediatric approach to evaluating a short child. , 2005, Pediatrics in review.

[16]  T. Trotter,et al.  Health Supervision for Children With Achondroplasia , 1995, Pediatrics.

[17]  Brenda J. Crowe,et al.  Effect of growth hormone treatment on adult height in peripubertal children with idiopathic short stature: a randomized, double-blind, placebo-controlled trial. , 2004, The Journal of clinical endocrinology and metabolism.

[18]  Y. Bilgili,et al.  Accuracy of Skeletal Age Assessment in Children From Birth to 6 Years of Age With the Ultrasonographic Version of the Greulich‐Pyle Atlas , 2003, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[19]  R. Milne,et al.  Recombinant growth hormone for idiopathic short stature in children and adolescents. , 2003, The Cochrane database of systematic reviews.

[20]  T. Cole Assessment of growth. , 2002, Best practice & research. Clinical endocrinology & metabolism.

[21]  E Pietka,et al.  Digital hand atlas and web-based bone age assessment: system design and implementation. , 2000, Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society.

[22]  L. Cox The biology of bone maturation and ageing , 1997, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[23]  T. Stijnen,et al.  Accuracy of final height prediction and effect of growth-reductive therapy in 362 constitutionally tall children. , 1996, The Journal of clinical endocrinology and metabolism.

[24]  D. Harris,et al.  Utah Growth Study: growth standards and the prevalence of growth hormone deficiency. , 1994, The Journal of pediatrics.

[25]  J. Tanner,et al.  Clinical longitudinal standards for height and height velocity for North American children. , 1985, The Journal of pediatrics.

[26]  J. M. Parkin Short stature. , 1976, British medical journal.